S069-0563 Screening compound: 3-methyl-1-{3-[5-(pyridin-4-yl)-1,2,4-oxadiazol-3-yl]pyrrolidin-1-yl}butan-1-one

S069-0563 Screening compound: 3-methyl-1-{3-[5-(pyridin-4-yl)-1,2,4-oxadiazol-3-yl]pyrrolidin-1-yl}butan-1-one
S069-0563 Screening compound: 3-methyl-1-{3-[5-(pyridin-4-yl)-1,2,4-oxadiazol-3-yl]pyrrolidin-1-yl}butan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S069-0563
3-methyl-1-{3-[5-(pyridin-4-yl)-1,2,4-oxadiazol-3-yl]pyrrolidin-1-yl}butan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S069-0563

Molecular Formula

C16H20N4O2 (C16 H20 N4 O2)

Compound Name

3-methyl-1-{3-[5-(pyridin-4-yl)-1,2,4-oxadiazol-3-yl]pyrrolidin-1-yl}butan-1-one

IUPAC name

3-methyl-1-{3-[5-(pyridin-4-yl)-124-oxadiazol-3-yl]pyrrolidin-1-yl}butan-1-one

SMILES

CC(C)CC(N(CC1)CC1c1noc(-c2ccncc2)n1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

300.36

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.248

Distribution Coefficient, logD

2.247

Water Solubility, LogSw

-2.11

Polar Surface Area

57.764

Acid Dissociation Constant (pKa)

24.55

Base Dissociation Constant (pKb)

4.57

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

S069-0563 in Drug Discovery

Included in Screening Libraries

CNS BBB Library (22607 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Nervous system
  • Eye
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Ion Channels
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S069-0563 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S069-0563?
Check Price and Availability of S069-0563, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S069-0563 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S069-0563
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S069-0563
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S069-0563 available by request